tiprankstipranks
Iovance Biotherapeutics Inc (IOVA)
NASDAQ:IOVA
US Market

Iovance Biotherapeutics (IOVA) Income Statement

Compare
3,177 Followers

Iovance Biotherapeutics Income Statement

Last quarter (Q3 2024), Iovance Biotherapeutics's total revenue was $58.55M, an increase of 12384.86% from the same quarter last year. In Q3, Iovance Biotherapeutics's net income was $-83.54M. See Iovance Biotherapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 1.19M$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -9.57M$ -21.14M$ -13.98M$ -8.71M$ -8.12M
Operating Expenses
$ 450.99M$ 398.88M$ 342.70M$ 261.94M$ 206.87M
Depreciation and Amortization
$ 33.13M$ 21.14M$ 13.98M$ 8.71M$ 8.12M
EBITDA
$ -427.43M$ -374.76M$ -328.27M$ -250.87M$ -189.43M
Operating Income
$ -460.56M$ -398.88M$ -342.70M$ -261.94M$ -206.87M
Other Income/Expenses
$ 13.04M$ 2.98M$ 451.00K$ 2.36M$ 9.32M
Pretax Income
$ -447.52M$ -395.89M$ -342.25M$ -259.58M$ -197.56M
Net Income
$ -444.04M$ -389.92M$ -327.82M$ -257.23M$ -187.07M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.89$ -2.45$ -2.14$ -1.86$ -1.50
Diluted EPS
$ -1.89$ -2.45$ -2.14$ -1.86$ -1.50
Weighted Average Shares Outstanding
235.13M 159.26M 153.41M 138.30M 124.34M
Weighted Average Shares Outstanding (Diluted)
235.13M 159.26M 153.41M 138.30M 124.34M
Currency in USD

Iovance Biotherapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis